Abstract:Quantitative, real-time detection of Ca2+ fluctuations in intracellular organelles is essential to determining the mechanism of Ca2+-dependent signaling. Here, we developed genetically encoded Ca2+ indicators by creating a Ca2+-binding site in the enhanced green fluorescent protein (EGFP). These novel biosensors allow real-time measurement without perturbing the cells’ Ca2+ signaling. Upon binding to Ca2+,these biosensors exhibit single-wavelength fluorescence enhancement and Kd values from 0.1 mM to 1 mM, which are optimal for detecting signaling in the skeletal muscle SR. Excessive biological metal ions, such as K+ or Na+, do not alter their ability to sense Ca2+. In particular, our CaratER can respond to various agonists and antagonists in C2C12, HeLa, and HEK-293 cells. It was expressed in the SR of FDB fibers and successfully monitored Ca2+ signaling under voltage-clamp and application of SR agonists. Its fluorescence decrease in response to sarcolemmal depolarization indicates its fast Ca2+ dissociation rate. These results match our stopped-flow kinetic analysis showing that 40-50% of the fluorescence change finished within the 2.2 ms deadtime, when EGTA rapidly mixed with Ca2+- saturated CaratER. We investigated our sensors’ optical and conformational properties using various spectroscopic methods, including high-resonance resolution NMR, and designed red fluorescent protein-based Ca2+ biosensors, which exhibit metal selectivity and large fluorescent changes in response to Ca2+. The pH stability was dramatically enhanced with apparent pKa below 5, so they can monitor Ca2+ signaling in deep tissues and small animals and detect simultaneous Ca2+ changes in various subcellular compartments with multiple colors. In conclusion, our molecular design method achieved biosensors that can reliably monitor Ca2+ signaling in high [Ca2+] environments.

A Silicon-Based Field-Effect Biosensor for Drug-Induced Cardiac Extracellular Calcium Ion Change Detection

Beating Cardiac Cell-Based Biosensor and Its Application in Drugs Screening

Cardiac Cell-based Biosensor and Its Biomedical Applications

Integrated Cell-Based Biosensor for Extracellular Electrophysiological Monitoring

A light-addressable potentiometric sensor-based extracellular calcium dynamic monitoring and imaging platform for cellular calcium channel drug evaluation

A novel design of multifunctional integrated cell-based biosensors for simultaneously detecting cell acidification and extracellular potential

A Novel Multi-Functional Cell-Based Microphysiometer

Cell-based biosensors based on light-addressable potentiometric sensors for single cell monitoring.

Detection of Heavy Metal Toxicity Using Cardiac Cell-Based Biosensor

In Vitro Assessing the Risk of Drug-Induced Cardiotoxicity by Embryonic Stem Cell-Based Biosensor

Microfluidic Chip System Integrated with Light Addressable Potentiometric Sensor (LAPS) for Real-Time Extracellular Acidification Detection

All-solid-state blood calcium sensors based on screen-printed poly(3,4-ethylenedioxythiophene) as the solid contact

The Single-Cell Biosensor For Monitoring Extracellular Action Potential And Evaluating Drugs

High-temporal-range Drug-Induced Cardiac Side-Effect Evaluation Using Simultaneous HL-1-based Impedance and Long-Term Electrophysiology Recording Systems

A novel microphysiometer based on MLAPS for drugs screening.

Drug evaluations using a novel microphysiometer based on cell-based biosensors

Design of Single-Cell Sensor Based on Light-Addressable Potentiometric Sensor

Label-free and highly-sensitive detection of calcium ions using a silicon-on-sapphire light-addressable potentiometric sensor

Electromechanical Integrated Recording of Single Cardiomyocyte in Situ by Multimodal Microelectrode Biosensing System.

A cardiomyocyte-based biosensor for antiarrhythmic drug evaluation by simultaneously monitoring cell growth and beating.

Rational Design and Structural Analysis of Calcium Biosensors and Their Application to the Study of Sr/Er Calcium Dynamics